Immix Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Immix Biopharma, Inc. has filed 235 SEC EDGAR filings since 20 Jul 2021

SEC filing history

Showing 151-175 of 235 matching filings.

Per page
25
Current page
7
DEFA14A File 001-41159

DEFA14A filing

Filing date
25 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-41159

ARS filing

Filing date
25 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-41159

DEF 14A filing

Filing date
25 Apr 2023
Reporting date
25 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-41159

10-K filing

Filing date
27 Mar 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
424B5 File 333-269100

424B5 filing

Filing date
22 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-41159

8-K/A filing

Filing date
13 Mar 2023
Reporting date
10 Mar 2023
Next action
Verify source filing
EFFECT File 333-269100

EFFECT filing

Filing date
11 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
09 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
06 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-269100

S-3 filing

Filing date
03 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-41159

10-Q filing

Filing date
09 Nov 2022
Reporting date
30 Sep 2022
Next action
Verify source filing
10-Q File 001-41159

10-Q filing

Filing date
12 Aug 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
4/A

4/A filing

Filing date
22 Jul 2022
Reporting date
14 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
RW File 333-265292

RW filing

Filing date
19 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jul 2022
Reporting date
14 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jul 2022
Reporting date
14 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jul 2022
Reporting date
14 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jul 2022
Reporting date
14 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .